Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Chubb · SciRah

Researcher profile · Semantic Scholar

B. Chubb

Share profile

B. Chubb — researcher profile on SciRah

h-index: 18
Works: 45
Citations: 768

Most-cited papers

Hypoglycaemia in adults with insulin‐treated diabetes in the UK: self‐reported frequency and effects
B. Frier, M. M. Jensen, B. Chubb
2015Diabetic Medicine60 citations Open access
Semantic Scholar
Is the future for clinical trials internet-based? A cluster randomized clinical trial
Jennifer Litchfield, J. Freeman, Henrik Schou, M. Elsley +2 more
2005Clinical Trials59 citations
Semantic Scholar
Cost‐effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin – from the UK health care cost perspective
M. Evans, M. Wolden, J. Gundgaard, B. Chubb +1 more
2014Diabetes, obesity and metabolism49 citations
Semantic Scholar
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK
S. Bain, Brian Bekker Hansen, B. Hunt, B. Chubb +1 more
2020Journal of Medical Economics48 citations Open access
Semantic Scholar
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
S. Bain, B. Hansen, S. Malkin, S. Nuhoho +4 more
2019Diabetes Therapy47 citations Open access
Semantic Scholar
Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey
M. Evans, H. H. Jensen, M. Bøgelund, J. Gundgaard +2 more
2013Journal of Medical Economics43 citations Open access
Semantic Scholar
Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK
M. Evans, M. Wolden, J. Gundgaard, B. Chubb +1 more
2015Journal of Medical Economics39 citations Open access
Semantic Scholar
Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis
B. Chubb, Palvi Gupta, Jatin Gupta, S. Nuhoho +2 more
2021Diabetes Therapy36 citations Open access
Semantic Scholar
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
M. Evans, B. Chubb, J. Gundgaard
2017Diabetes Therapy29 citations Open access
Semantic Scholar
Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting
M. Davies, D. Glah, B. Chubb, G. Konidaris +1 more
2016PharmacoEconomics (Auckland)28 citations Open access
Semantic Scholar
Obesity and healthcare resource utilization: comparative results from the UK and the USA
E. Nørtoft, B. Chubb, A. Borglykke
2017Obesity Science & Practice27 citations Open access
Semantic Scholar
Approach to assessing the economic impact of insulin‐related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool
W. Parekh, D. Ashley, B. Chubb, H. Gillies +1 more
2015Diabetic Medicine26 citations Open access
Semantic Scholar
Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective
S. Harris, K. Khunti, M. Landin-Olsson, Claus B Galbo-Jørgensen +4 more
2013Patient Preference and Adherence26 citations Open access
Semantic Scholar
Obesity and healthcare resource utilization: results from Clinical Practice Research Database (CPRD)
C. L. le Roux, B. Chubb, E. Nørtoft, A. Borglykke
2018Obesity Science & Practice25 citations Open access
Semantic Scholar
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
P. Johansen, B. Chubb, B. Hunt, S. Malkin +2 more
2020Advances in Therapy24 citations Open access
Semantic Scholar
An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg
R. Pratley, A. Catarig, I. Lingvay, A. Viljoen +5 more
2021Diabetes, obesity and metabolism22 citations Open access
Semantic Scholar
Frequency of blood glucose testing among insulin-treated diabetes mellitus patients in the United Kingdom
Won Chan Lee, Elise Smith, B. Chubb, M. Wolden
2014Journal of Medical Economics21 citations Open access
Semantic Scholar
Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting
M. Evans, R. Mehta, J. Gundgaard, B. Chubb
2018Diabetes Therapy19 citations Open access
Semantic Scholar
The Cost of Non-Severe Hypoglycaemia In Europe.
B. Chubb, C. Tikkanen
2015Value in Health17 citations Open access
Semantic Scholar
The cost of needlestick injuries associated with insulin administration.
P. Trueman, Matthew Taylor, N. Twena, B. Chubb
2008British Journal of Community Nursing17 citations
Semantic Scholar
The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials.
S. Malkin, B. Hunt, E. Huisman, T. S. Grand +1 more
2021Diabetes Research and Clinical Practice16 citations Open access
Semantic Scholar
Preference for Type 2 Diabetes Therapies in the United States: A Discrete Choice Experiment
J. Shubrook, M. Radin, S. Ali, B. Chubb +4 more
2022Advances in Therapy15 citations Open access
Semantic Scholar
Development and validation of a cost–utility model for Type 1 diabetes mellitus
S. Wolowacz, I. Pearson, P. Shannon, B. Chubb +3 more
2015Diabetic Medicine12 citations
Semantic Scholar
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting
B. Eliasson, Å. Ericsson, A. Fridhammar, A. Nilsson +2 more
2022PharmacoEconomics - Open11 citations Open access
Semantic Scholar
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia
N. Lalic, M. Russel-Szymczyk, M. Culic, C. Tikkanen +1 more
2018Diabetes Therapy10 citations Open access
Semantic Scholar
Once‐weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long‐term cost‐effectiveness analysis based on SUSTAIN 11
M. Evans, B. Chubb, Samuel J. P. Malkin, S. Berry +2 more
2022Diabetes, obesity and metabolism8 citations Open access
Semantic Scholar
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
R. Pollock, B. Chubb, W. Valentine, S. Heller
2018Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy6 citations Open access
Semantic Scholar
Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide
S. Berry, B. Chubb, A. Acs, E. Falla +4 more
2023Journal of Medical Economics5 citations Open access
Semantic Scholar
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK
A. Viljoen, B. Chubb, S. Malkin, S. Berry +2 more
2022European Journal of Health Economics5 citations Open access
Semantic Scholar
Self-Reported Frequency and Impact of Non-Severe Hypoglycaemia in Insulin-Treated Adults in the UK.
B. Chubb, M. M. Jensen, B. Frier
2014Value in Health5 citations Open access
Semantic Scholar
Modelling Cardiovascular Outcomes In Type 2 Diabetes In The ERA Of Cardiovascular Outcomes Trials
P. McEwan, B. Chubb, H. Bennett
20173 citations Open access
Semantic Scholar
The Relationship Between Glucose-Lowering Medications, Adherence, and Outcomes in Patients with Type 2 Diabetes.
J. Piercy, G. Milligan, M. Davies, B. Detournay +5 more
2015Value in Health3 citations Open access
Semantic Scholar
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
I. Lingvay, A. Catarig, J. Lawson, B. Chubb +2 more
2022Diabetes Therapy2 citations Open access
Semantic Scholar
Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom
B. Chubb, M. Evans, M. Wolden, T. Christensen +1 more
20132 citations Open access
Semantic Scholar
Assessment of Carbon Emission Impact of Semaglutide in Patients With Type 2 Diabetes in the United Kingdom Using an Innovative Modeling Approach.
Niels Lund, Andreas Rasche, Matthew Taylor, B. Chubb +4 more
2026Value in Health1 citations
Semantic Scholar
PDB25 The Cost-Effectiveness of ORAL Semaglutide in Patients Treated with Currently Available GLP-1 Receptor Agonists - a UK Perspective
B. Chubb, D. Glah, M. Capehorn
20201 citations Open access
Semantic Scholar
Flexible Insulin Dosing Improves Health-Related Quality of Life (HRQoL): A Time Trade-off Survey
D. Groleau, M. Evans, H. H. Jensen, M. Bøgelund +3 more
20131 citations
Semantic Scholar
PDB19 A Systematic Review of Recent Data Describing the Risk of Complications in Type 1 Diabetes Mellitus Patients
I. Pearson, S. Wolowacz, A. Irving, J. Brockbank +4 more
20121 citations Open access
Semantic Scholar
Article: Health Economics
M. J. Davies, B. Chubb, I. Smith, W. Valentine
1 citations
Semantic Scholar
790-P: An Indirect Treatment Comparison of the Cardiovascular Protective Effect of Semaglutide vs. Liraglutide in Subjects with Type 2 Diabetes
B. Chubb, M. Bøg
2023Diabetes0 citations
Semantic Scholar
Author response for "An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg"
R. Pratley, Andrei-Mircea Catarig, Ildiko Lingvay, A. Viljoen +5 more
20210 citations Open access
Semantic Scholar
Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia
M. Culic, M. Russel-Szymczyk, B. Chubb, C. Tikkanen
20160 citations Open access
Semantic Scholar
Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine for Patients with Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom
M. Evans, B. Chubb, T. Christensen, J. Gundgaard +1 more
20130 citations Open access
Semantic Scholar
IMPACT OF TREATMENT COMPLIANCE ON HBA1C IN PEOPLE WITH TYPE 2 DIABETES USING INSULIN
B. Chubb
20130 citations
Semantic Scholar
PDB39 EFFECT OF VARYING MODELLING ASSUMPTIONS ON THE COSTEFFECTIVENESS OF LIRAGLUTIDE 1.2 MG (AS A COMPONENT OF DUAL THERAPY) IN TYPE 2 DIABETES
W. Valentine, B. Chubb, I. Smith
20100 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Gundgaard×11
Invite
J. Gundgaard — researcher profile on SciRah
M. Evans×10
Invite
M. Evans — researcher profile on SciRah
B. Hunt×7
Invite
B. Hunt — researcher profile on SciRah
M. Wolden×5
Invite
M. Wolden — researcher profile on SciRah

×5

Invite

W. Valentine — researcher profile on SciRah

Invite

S. Malkin — researcher profile on SciRah

Invite

J. Lawson — researcher profile on SciRah

T. Christensen×3

Invite

T. Christensen — researcher profile on SciRah

Invite

M. Capehorn — researcher profile on SciRah

M. Bøgelund×3

Invite

M. Bøgelund — researcher profile on SciRah

Invite

K. Khunti — researcher profile on SciRah

Invite

A. Viljoen — researcher profile on SciRah